Temporary deafferentation evoked by cutaneous anesthesia: behavioral and electrophysiological findings in healthy subjects Aida SehleImke BüschingJoachim Liepert Translational Neurosciences - Original Article 16 March 2016 Pages: 473 - 480
Comparison of baroreflex sensitivity estimated from ECG R–R and inter-systolic intervals obtained by finger plethysmography and radial tonometry Juliane ViehwegManja ReimannTjalf Ziemssen Translational Neurosciences - Original Article 17 March 2016 Pages: 481 - 490
Rasagiline prevents cyclosporine A-sensitive superoxide flashes induced by PK11195, the initial signal of mitochondrial membrane permeabilization and apoptosis Yuqiu WuMasayo Shamoto-NagaiMakoto Naoi Translational Neurosciences - Short communication 02 March 2016 Pages: 491 - 494
Secondary task performance during challenging walking tasks and freezing episodes in Parkinson’s disease Valeria DibilioClaudia StummerVivian Weerdesteyn Neurology and Preclinical Neurological Studies - Original Article Open access 31 March 2016 Pages: 495 - 501
Dysfunction in attentional processing in patients with Parkinson’s disease and visual hallucinations Julie M. HallClaire O’CallaghanAhmed A. Moustafa Neurology and Preclinical Neurological Studies - Short communication 03 March 2016 Pages: 503 - 507
Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI Daniela FrosiniRoberto CeravoloMirco Cosottini Neurology and Preclinical Neurological Studies - Short communication 04 March 2016 Pages: 509 - 513
Quantification of sound instability in embouchure tremor based on the time-varying fundamental frequency André LeeJakob VogetEckart Altenmüller Neurology and Preclinical Neurological Studies - Original Article 29 March 2016 Pages: 515 - 521
Reconstituting botulinum toxin drugs: shaking, stirring or what? Dirk DresslerHans Bigalke Neurology and Preclinical Neurological Studies - Original Article 21 April 2016 Pages: 523 - 525
Botulinum toxin therapy: reduction of injection site pain by pH normalisation Dirk DresslerFereshte Adib SaberiHans Bigalke Neurology and Preclinical Neurological Studies - Original Article 22 March 2016 Pages: 527 - 531
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting Katja KolleweClaus M. EscherDirk Dressler Neurology and Preclinical Neurological Studies - Original Article 31 March 2016 Pages: 533 - 540
Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes David KovacsNora EszlariGabriella Juhasz Psychiatry and Preclinical Psychiatric Studies - Original Article Open access 28 January 2016 Pages: 541 - 548
Treatment escalation in patients not responding to pharmacotherapy, psychotherapy, and electro-convulsive therapy: experiences from a novel regimen using intravenous S-ketamine as add-on therapy in treatment-resistant depression Bernd KallmünzerBastian VolbersHelge H. Müller Psychiatry and Preclinical Psychiatric Studies - Short communication 31 December 2015 Pages: 549 - 552